BioMarin Pharmaceuticals BMRN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $520.42M-20.8% | $657.24M+25.5% | $523.88M+22.7% | ||
| $73.9M-7.1% | $79.56M-3.8% | $82.73M-0.6% | $83.25M-8.7% | $91.15M-5.5% | ||
| $187.17M+3.2% | $181.41M-2.7% | $186.42M+3.2% | $180.64M-0.2% | $181.02M-10.2% | ||
| $874.25M+5.6% | $827.99M-9.4% | $913.98M+19.2% | $766.77M+9.5% | $700.26M+22.2% | ||
| $107.19M+4.0% | $103.04M+25.9% | $81.85M+13.9% | $71.86M-5.6% | $76.09M-10.9% | ||
| $339.52M+182% | -$414.24M-40.2% | -$295.39M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $806.4M+1,870% | -$45.55M— | —— | —— | —— | ||
| $2.02B+449% | $368.84M-35.8% | $574.66M+138% | $241.67M-19.9% | $301.81M+60.8% | ||
| $767.06M+5.8% | $724.96M-12.9% | $832.13M+19.7% | $694.91M+11.3% | $624.18M+28.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioMarin Pharmaceuticals generate?
- BioMarin Pharmaceuticals (BMRN) generated $874.3M in operating cash flow over the trailing twelve months.
- What is BioMarin Pharmaceuticals's free cash flow?
- After $107.2M of capital expenditures, BioMarin Pharmaceuticals's free cash flow was $767.1M over the trailing twelve months, up 22.9% year over year.
- Where does BioMarin Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
